Akshay Khandelwal is a Cardiology physician. OpenAlex indexes 98 publications with 2,042 citations (h-index 19).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
12311 Perry Hwy
Wexford, PA 150908344
Telephone
878-332-4214Provider last certified this registry record 9 Jul 2024.
Industry payments
11 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Cook Medical LLCProgram year20251 payment
- Philips North America LLCProgram year20251 payment
- Edwards Lifesciences CorporationProgram year20242 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
86.3%Beta blocker28.1%Metoprolol Succinate65%Carvedilol24%Metoprolol Tartrate11%Part D≥37 patientsStatin20.9%Rosuvastatin Calcium55%Atorvastatin Calcium45%Part D≥41 patients+ 8 more classes in this area
Blood & clotting
13.7%Factor Xa inhibitor11.2%Eliquis100%Part D≥28 patientsP2Y12 inhibitor2.5%Clopidogrel100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Safety and Complications Associated With the Use of Protamine in Percutaneous Coronary Intervention
The Journal of invasive cardiology/The journal of invasive cardiology
2025 - Feasibility and Outcomes of a Cardiovascular Medicine Inclusive Extracorporeal Membrane Oxygenation (ECMO) Service
Journal of the Society for Cardiovascular Angiography & Interventions
2024 - Periapical Healing following Root Canal Treatment Using Different Endodontic Sealers: A Systematic Review
BioMed Research International
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”